Parsawa Medical Injection Products Manufacturing Company was established in 2017 with the goal of producing and supplying medical injection products. Relying on local scientific expertise and supported by private sector investment in the country, the company was launched to contribute to the domestic medical industry. After extensive research and careful studies, mass production of the company's medical materials and products began in 2019, utilizing modern global technologies and adhering to international medical standards.
Project Goals
Main Goal: To transform Parsawa Company into a hub for the production of medical injection products in the region's countries.
Sub Goals:
1- To meet the domestic demand for medical injection serums, including Dextrose Serum, Normal Saline Serum, Ringer's Serum, and Mix Serum in 500 and 1000 ml packaging.
2- To meet the domestic demand for medical injectable antibiotics, including Ciprofloxacin and Metronidazole.
3- To meet the domestic demand for other medical injectable ampoules, including distilled water and Vitamin C, D, and B Complex.